- Corporate Officers - G
- Garcia Peter S
Insider Trading History of Garcia Peter S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Garcia Peter S since 2011.
This trader's CIK number is 1188956.
At the time of last reporting, Garcia Peter S was the CHIEF FINANCIAL OFFICER of Alx Oncology Holdings Inc. (stock ticker symbol ALXO).
Also see all insider trading activities at Alx Oncology Holdings Inc.
Note that in the past
GARCIA PETER S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Lineage Cell Therapeutics, Inc. (BTX) by Garcia Peter S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | BTX | 5,000 | $23,384 | 0 | $0 | 0 | $0 |
| 2011 | BTX | 2,000 | $8,340 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alx Oncology Holdings Inc (ALXO) by Garcia Peter S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | ALXO | 12,000 | $102,336 | 1,893 | $28,470 | 0 | $0 |
| 2023 | ALXO | 0 | $0 | 1,780 | $16,395 | 0 | $0 |
| 2022 | ALXO | 0 | $0 | 0 | $0 | 15,000 | $66,675 |
| 2021 | ALXO | 0 | $0 | 90,000 | $6,552,760 | 96,128 | $392,201 |
| 2020 | ALXO | 3,000 | $57,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pdl Biopharma, Inc. (PDLI) by Garcia Peter S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | PDLI | 25,000 | $49,400 | 0 | $0 | 0 | $0 |
| 2016 | PDLI | 10,000 | $29,950 | 0 | $0 | 0 | $0 |
| 2015 | PDLI | 35,000 | $168,980 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Garcia Peter S:
1. Lineage Cell Therapeutics, Inc. (BTX)
2. Alx Oncology Holdings Inc (ALXO)
3. Pdl Biopharma, Inc. (PDLI)
Table 1. Insider trading of Lineage Cell Therapeutics, Inc. (BTX) by Garcia Peter S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-03-19 | BTX | Buy | 5,000 | 4.68 | 23,384 |
| 2011-11-29 | BTX | Buy | 2,000 | 4.17 | 8,340 |
Table 2. Insider trading of Alx Oncology Holdings Inc (ALXO) by Garcia Peter S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-13 | ALXO | Buy | 12,000 | 8.53 | 102,336 |
| 2023-12-29 | ALXO | Sale | 1,893 | 15.04 | 28,470 |
| 2023-06-30 | ALXO | Sale | 887 | 7.34 | 6,510 |
| 2022-12-29 | ALXO | Sale | 893 | 11.07 | 9,885 |
| 2022-02-07 | ALXO | Option Ex | 15,000 | 4.45 | 66,675 |
| 2021-10-18 | ALXO | Sale | 7,229 | 56.75 | 410,216 |
| 2021-10-18 | ALXO | Option Ex | 7,229 | 4.08 | 29,494 |
| 2021-09-16 | ALXO | Sale | 1,426 | 80.43 | 114,694 |
| 2021-09-17 | ALXO | Sale | 11,345 | 79.47 | 901,530 |
| 2021-09-16 | ALXO | Option Ex | 1,426 | 4.08 | 5,818 |
| 2021-09-17 | ALXO | Option Ex | 11,345 | 4.08 | 46,287 |
| 2021-08-23 | ALXO | Option Ex | 60,000 | 4.08 | 244,800 |
| 2021-08-23 | ALXO | Sale | 60,000 | 74.27 | 4,456,020 |
| 2021-08-17 | ALXO | Option Ex | 10,000 | 4.08 | 40,800 |
| 2021-08-17 | ALXO | Sale | 10,000 | 67.03 | 670,300 |
| 2021-01-28 | ALXO | Option Ex | 6,128 | 4.08 | 25,002 |
| 2020-07-21 | ALXO | Buy | 3,000 | 19.00 | 57,000 |
Table 3. Insider trading of Pdl Biopharma, Inc. (PDLI) by Garcia Peter S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-03-24 | PDLI | Buy | 25,000 | 1.98 | 49,400 |
| 2016-08-09 | PDLI | Buy | 10,000 | 3.00 | 29,950 |
| 2015-12-15 | PDLI | Buy | 5,000 | 3.64 | 18,200 |
| 2015-12-14 | PDLI | Buy | 10,000 | 3.42 | 34,250 |
| 2015-08-13 | PDLI | Buy | 10,000 | 5.86 | 58,600 |
| 2015-08-14 | PDLI | Buy | 10,000 | 5.79 | 57,930 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Garcia Peter S
(CHIEF FINANCIAL OFFICER of Alx Oncology Holdings Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.